| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $28.8M | -24.2% |
| R&D Expense | $167.3M | -4.8% |
| SG&A Expense | $72.7M | +19.2% |
| Operating Income | -$314.8M | -32.7% |
| Pre-tax Income | -$200.4M | -15.2% |
| Income Tax | -$37.5M | -35.9% |
| Net Income | -$162.9M | -11.2% |
| EPS (Basic) | -$0.55 | -7.8% |
| EPS (Diluted) | -$0.55 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $156.3M | +17.3% |
| Accounts Receivable | $32.0M | — |
| Current Assets | $751.4M | -13.8% |
| Total Assets | $1.36B | -8.6% |
| Current Liabilities | $76.6M | -35.6% |
| Total Liabilities | $304.5M | -9.3% |
| Stockholders' Equity | $1.06B | -8.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.6M | -147.4% |
| Capital Expenditures | $78.4M | +1.9% |
| Investing Cash Flow | $121.4M | +154.9% |
| Financing Cash Flow | $12.8M | +23.3% |
| Free Cash Flow | -$187.0M | -54.7% |
| -7.8% |